These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19582472)

  • 21. A prospective randomized trial of intravitreal bevacizumab versus ranibizumab for the management of diabetic macular edema.
    Nepomuceno AB; Takaki E; Paes de Almeida FP; Peroni R; Cardillo JA; Siqueira RC; Scott IU; Messias A; Jorge R
    Am J Ophthalmol; 2013 Sep; 156(3):502-510.e2. PubMed ID: 23795985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.
    Fang X; Sakaguchi H; Gomi F; Oshima Y; Sawa M; Tsujikawa M; Ikuno Y; Kamei M; Kusaka S; Tano Y
    Acta Ophthalmol; 2008 Nov; 86(7):800-5. PubMed ID: 18547274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.
    Faghihi H; Roohipoor R; Mohammadi SF; Hojat-Jalali K; Mirshahi A; Lashay A; Piri N; Faghihi Sh
    Eur J Ophthalmol; 2008; 18(6):941-8. PubMed ID: 18988166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema.
    Shimura M; Yasuda K; Yasuda M; Nakazawa T
    Retina; 2013 Apr; 33(4):740-7. PubMed ID: 23222391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal bevacizumab treatment of macular edema due to optic disc vasculitis.
    Erdurman FC; Durukan AH; Mumcuoğlu T; Hürmeriç V
    Ocul Immunol Inflamm; 2009; 17(1):56-8. PubMed ID: 19294575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
    Shah SU; Harless A; Bleau L; Maturi RK
    Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up.
    Cervantes-Castañeda RA; Giuliari GP; Gallagher MJ; Yilmaz T; MacDonell RE; Quinones K; Foster CS
    Eur J Ophthalmol; 2009; 19(4):622-9. PubMed ID: 19551679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.
    ; Scott IU; Edwards AR; Beck RW; Bressler NM; Chan CK; Elman MJ; Friedman SM; Greven CM; Maturi RK; Pieramici DJ; Shami M; Singerman LJ; Stockdale CR
    Ophthalmology; 2007 Oct; 114(10):1860-7. PubMed ID: 17698196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up.
    Arevalo JF; Fromow-Guerra J; Quiroz-Mercado H; Sanchez JG; Wu L; Maia M; Berrocal MH; Solis-Vivanco A; Farah ME;
    Ophthalmology; 2007 Apr; 114(4):743-50. PubMed ID: 17398322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
    Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and Therapeutic Challenges.
    Uparkar MP; Kaul S; Manning DR; Mudvari SS
    Retina; 2016 Mar; 36(3):641-4. PubMed ID: 26492386
    [No Abstract]   [Full Text] [Related]  

  • 33. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of unilateral intravitreal bevacizumab (avastin), in the treatment of diffuse bilateral diabetic macular edema: a pilot study.
    Velez-Montoya R; Fromow-Guerra J; Burgos O; Landers MB; Morales-Catón V; Quiroz-Mercado H
    Retina; 2009 Jan; 29(1):20-6. PubMed ID: 18784623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema.
    Goel N; Kumar V; Ghosh B
    Int Ophthalmol; 2011 Feb; 31(1):39-42. PubMed ID: 20852916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: does it really work?
    Spitzer MS; Szurman P; Bartz-Schmidt KU
    J Cataract Refract Surg; 2008 Jun; 34(6):880; author reply 880-1. PubMed ID: 18498977
    [No Abstract]   [Full Text] [Related]  

  • 37. Features of optical coherence tomography are predictive of visual outcomes after intravitreal bevacizumab injection for diabetic macular edema.
    Roh MI; Kim JH; Kwon OW
    Ophthalmologica; 2010; 224(6):374-80. PubMed ID: 20453545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).
    Wu L; Martínez-Castellanos MA; Quiroz-Mercado H; Arevalo JF; Berrocal MH; Farah ME; Maia M; Roca JA; Rodriguez FJ;
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):81-7. PubMed ID: 17674014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern electroretinogram changes after intravitreal bevacizumab injection for diabetic macular edema.
    Ozkiriş A
    Doc Ophthalmol; 2010 Jun; 120(3):243-50. PubMed ID: 20140695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract.
    Akinci A; Batman C; Ozkilic E; Altinsoy A
    Retina; 2009; 29(10):1432-5. PubMed ID: 19898181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.